Shionogi & Co., Ltd. (SGIOF)
OTCMKTS
· Delayed Price · Currency is USD
18.05
0.00 (0.00%)
At close: Jun 25, 2025
Shionogi & Revenue
In the fiscal year ending March 31, 2025, Shionogi & had annual revenue of 438.30B JPY with 0.74% growth. Shionogi & had revenue of 104.70B in the quarter ending March 31, 2025, with 6.55% growth.
Revenue
438.30B JPY
Revenue Growth
+0.74%
P/S Ratio
5.09
Revenue / Employee
88.46M JPY
Employees
4,955
Market Cap
14.89B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 438.30B | 3.22B | 0.74% |
| Mar 31, 2024 | 435.08B | 8.40B | 1.97% |
| Mar 31, 2023 | 426.68B | 91.55B | 27.32% |
| Mar 31, 2022 | 335.14B | 37.96B | 12.77% |
| Mar 31, 2021 | 297.18B | -36.19B | -10.86% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Shionogi & News
- 6 weeks ago - Shionogi & Co. GAAP EPS of ¥200.29, revenue of ¥438.27B - Seeking Alpha
- 7 weeks ago - Shionogi to buy Japan Tobacco’s Torii Pharma in a deal worth over $1B - Seeking Alpha
- 5 months ago - Shionogi and Jordan's Guardian Angels Announce First-Ever Human Drug Study for Jordan's Syndrome, an Ultra-Rare Genetic Neurodevelopmental Disorder - Benzinga
- 5 months ago - Shionogi & Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 5 months ago - Shionogi targets JPY550B revenue through QOL focus and global expansion - Seeking Alpha
- 5 months ago - Shionogi & Co., Ltd. (SGIOY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Shionogi & Co. reports 9M results - Seeking Alpha
- 8 months ago - Shionogi & Co., Ltd. (SGIOY) Q2 2024 Earnings Call Transcript - Seeking Alpha